Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23978025 | 0.80 | ALDH1A1 (0.37) | ALDH1A1KMT2ALMNAKDM4ENPC1 | |
| SCHEMBL23965671 | 0.74 | HIF1A (0.44) | KMT2ALMNANPC1SMN1; SMN2RAB9A | |
| SCHEMBL23969523 | 0.73 | HPGD (0.37) | KMT2ALMNANPC1RAB9A | |
| SCHEMBL23969511 | 0.71 | S1PR1 (0.40) | ALDH1A1NPC1SMN1; SMN2RAB9A | |
| SCHEMBL23971813 | 0.70 | HIF1A (0.56) | ALDH1A1KMT2ALMNAKDM4ENPC1 | |
| SCHEMBL23969485 | 0.68 | HIF1A (0.46) | NPC1SMN1; SMN2RAB9A | |
| SCHEMBL12779054 | 0.64 | ALDH1A1 (0.40) | ALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL23984127 | 0.64 | ALDH1A1 (0.32) | ALDH1A1KMT2ALMNAKDM4ENPC1 | |
| SCHEMBL6815533 | 0.64 | SMN1; SMN2 (0.46) | ALDH1A1KMT2ALMNAKDM4ENPC1 | |
| SCHEMBL23965621 | 0.63 | ALDH1A1 (0.38) | ALDH1A1KMT2ALMNANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3903584-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS IV | BASF SE (DE) | 2021-11-03 | — | — | EP | disclosed |
| EP-3903582-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II | BASF SE (DE) | 2021-11-03 | — | — | EP | disclosed |